Trifluridine

From Wikipedia, the free encyclopedia

Trifluridine
Systematic (IUPAC) name
1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5- (trifluoromethyl) pyrimidine-2,4-dione
Identifiers
CAS number 70-00-8
ATC code S01AD02
PubChem 6256
DrugBank APRD01275
Chemical data
Formula C10H11F3N2O5 
Mol. mass 296.2 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life 12 minutes
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status

Prescription only

Routes Eye drops

Trifluridine is an anti-herpesvirus antiviral drug, used primarily on the eye. It was sold under the trade name, Viroptic, by Glaxo Wellcome, now merged into GlaxoSmithKline. The brand is now owned by Monarch Pharmaceuticals, which is wholly owned by King Pharmaceuticals.

[edit] External links

  • Costin D, Dogaru M, Popa A, Cijevschi I. "Trifluridine therapy in herpetic in keratitis". Rev Med Chir Soc Med Nat Iasi 108 (2): 409-12. PMID 15688823. 
  • Kuster P, Taravella M, Gelinas M, Stepp P (1998). "Delivery of trifluridine to human cornea and aqueous using collagen shields.". CLAO J 24 (2): 122-4. PMID 9571274. 
  • O'Brien W, Taylor J (1991). "Therapeutic response of herpes simplex virus-induced corneal edema to trifluridine in combination with immunosuppressive agents.". Invest Ophthalmol Vis Sci 32 (9): 2455-61. PMID 1907950. 
  • Trifluridine Opthalmic Solution, 1% (PDF). Retrieved on March 24, 2007.